These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30988807)

  • 1. Identification of key genes involved in the metastasis of clear cell renal cell carcinoma.
    Wei W; Lv Y; Gan Z; Zhang Y; Han X; Xu Z
    Oncol Lett; 2019 May; 17(5):4321-4328. PubMed ID: 30988807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.
    Zhang H; Zou J; Yin Y; Zhang B; Hu Y; Wang J; Mu H
    PeerJ; 2019; 7():e8096. PubMed ID: 31788359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Core Genes Involved in the Metastasis of Clear Cell Renal Cell Carcinoma.
    Peng R; Wang Y; Mao L; Fang F; Guan H
    Cancer Manag Res; 2020; 12():13437-13449. PubMed ID: 33408516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of hub genes associated with outcome of clear cell renal cell carcinoma.
    Li R; Wang L; Wang X; Geng RX; Li N; Liu XH
    Oncol Lett; 2020 Apr; 19(4):2846-2860. PubMed ID: 32218839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).
    Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y
    Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.
    Bao L; Zhao Y; Liu C; Cao Q; Huang Y; Chen K; Song Z
    J Cancer; 2020; 11(7):1712-1726. PubMed ID: 32194783
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
    Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
    Front Genet; 2020; 11():530892. PubMed ID: 33061942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.
    Cui H; Xu L; Li Z; Hou KZ; Che XF; Liu BF; Liu YP; Qu XJ
    Oncol Lett; 2020 Aug; 20(2):1573-1584. PubMed ID: 32724399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ATP6V0A4 as a potential biomarker in renal cell carcinoma using integrated bioinformatics analysis.
    Xu J; Jiang J; Yin C; Wang Y; Shi B
    Oncol Lett; 2023 Sep; 26(3):366. PubMed ID: 37559594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
    Qu G; Wang H; Yan H; Liu G; Wu M
    Front Oncol; 2022; 12():857619. PubMed ID: 35296026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
    Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
    Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S
    Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis.
    Liao Y; Yin G; Wang X; Zhong P; Fan X; Huang C
    Oncol Lett; 2019 Oct; 18(4):3723-3733. PubMed ID: 31516585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
    Shi Y; Li Y; Yan C; Su H; Ying K
    Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.
    Sui Y; Lu K; Fu L
    PeerJ; 2021; 9():e11272. PubMed ID: 33976979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
    Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
    Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis.
    Zhang N; Chen W; Gan Z; Abudurexiti A; Hu X; Sang W
    Medicine (Baltimore); 2020 May; 99(21):e20470. PubMed ID: 32481352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
    Wang S; Yu ZH; Chai KQ
    Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.